Adial Pharmaceuticals gets Nasdaq notice for falling below $2.5 million stockholders’ equity minimumPUBT·1 hour agoADIL+5.34%
Adial Pharmaceuticals reports $52.0M Q2 net loss, cash $28.7M after $32M financingTradingView·Aug 17 at 06:23 AMADIL+5.34%
Adial Pharma Faces Governance Risks and Major Dilution as 2026 Shareholder Vote Looms on Preferred Conversions and WarrantsTip Ranks·Aug 16 at 01:00 AMADIL+5.34%
Adial Pharmaceuticals CEO Cary Claiborne set to depart after Sept. 17 annual meeting; CDO Matthew Davidson slated to succeedPUBT·Aug 13 at 04:26 PMADIL+5.34%
Coastlands Capital LP reports Adial Pharmaceuticals common share purchase worth $32,613.87PUBT·Jul 13 at 09:31 AMADIL+5.34%
Pricing Divergence Amid Liquidity Shifts: A Microcosm of Cross-Border RisksGlobal Report·Jul 9 at 09:02 PMXYF-2.00%BQ-4.00%
